New Enterprise Associates

New Enterprise Associates, Inc. is a private equity and venture capital firm established in 1977 and headquartered in Menlo Park, California, with additional offices in India and China. The firm specializes in investments across various stages of company development, including seed, start-up, early stage, and later stage, with a focus on sectors such as information technology, healthcare, and energy technology. NEA's investment strategy encompasses a wide range of industries, including consumer internet, software, biotechnology, medical devices, and alternative energy. With over $19 billion in cumulative committed capital, the firm has a notable track record, having participated in more than 210 portfolio company IPOs and over 360 acquisitions. NEA aims to invest between $0.05 million and $20 million, targeting both domestic and international markets, particularly in Asia and the Americas.

Michael James Barrett

Partner Emeritus

Kate Barrett

Marketing Partner

Peter J. Barris

Chairman

Ronald D. Bernal

Venture Partner

Ron Bernal

Venture Partner

Tak Cheung

Partner

Philip Chopin

Managing Director

Louis Citron

Chief Administrative Officer and Chief Legal Officer

Robert Croce

Venture Advisor

Bala Deshpande

Sr. Managing Director, India

Lexi Eisenberg

Associate

Anthony A. Florence

Managing General Partner, Technology

Tony Florence

General Partner

Carol Gallagher

Advisor

Tracy Howe

Investment Professional

Suzanne Hooper King

Partner

Liza Landsman

General Partner

Michael Li

Investor

Tiffany Luck

Partner

Joshua Makower

General Partner

Edward T. Mathers

Partner

John Nehra

Retired Special Partner

Michael D. O'Dell

Venture Partner

Santhosh Palani

Principal

Greg Papadopoulos

Venture Partner

Michele Park

Partner

Arno Allan Penzias

Venture Advisor

Eugene A. Trainor

COO

James G. Treybig

Venture Advisor

Paul Walker

General Partner

Harry Weller

Former General Partner

Past deals in Northeastern US

Flox

Series A in 2023
Flox is taking nix to work for building software and managing development environments.

X4 Pharmaceuticals

Post in 2022
X4 Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, focused on developing innovative therapeutics for primary immune deficiencies and cancer. The company's lead drug candidate, mavorixafor, is an oral small molecule antagonist of the CXCR4 chemokine receptor, currently undergoing various clinical trials. Mavorixafor is in Phase III trials for treating patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome, and is also being tested in Phase Ib trials for severe congenital neutropenia and Waldenström macroglobulinemia, alongside a Phase IIa trial for clear cell renal cell carcinoma. Additionally, X4 Pharmaceuticals is advancing X4P-002, aimed at treating glioblastoma multiforme, and is developing X4P-003 for primary immune deficiencies. The company has established a license agreement with Abbisko Therapeutics to explore the use of mavorixafor in combination with checkpoint inhibitors for oncology applications. Founded in 2014, X4 Pharmaceuticals was previously known as Arsanis, Inc. before rebranding in March 2019.

Regression Games

Seed Round in 2022
Regression Games focuses on enhancing competitive gaming through artificial intelligence. The company develops tools aimed at simplifying the game development process, offering a platform that automates quality assurance and game balancing. By utilizing AI agents, Regression Games ensures that automation is efficient and effective, allowing game developers to streamline their workflows. This approach not only supports studios in improving their games but also makes AI-driven gaming experiences more accessible and enjoyable for players.

Narmi

Series B in 2022
Narmi Inc. is a technology company that specializes in developing online and mobile banking applications for regional and community financial institutions in the United States. Founded in 2016 and headquartered in New York City, Narmi aims to enhance the banking experience by providing a platform that allows these institutions to attract, engage, and retain customers more effectively. Their offerings include features such as online banking, account opening with fraud protection, and multi-factor authentication, all designed to streamline financial transactions and improve customer interaction. By equipping regional and community banks with advanced technology, Narmi helps them compete against larger banks and FinTech companies, fostering a more diverse and engaging financial ecosystem. In addition to its banking applications, Narmi also provides website design, development, and hosting services, as well as content generation and management solutions.

Nodar

Series A in 2022
Nodar, Inc. specializes in manufacturing advanced sensors for various transportation modes, including cars, trucks, drones, ships, trains, and aircraft. The company offers innovative LiDAR technology and a 3D stereo vision system called Nodar Longbow, which is designed to enhance the capabilities of autonomous vehicles. Founded in 2018 and based in Boston, Massachusetts, Nodar aims to provide a cost-effective and high-performance solution for the automotive, marine, and railway industries. Their products, including the Hammerhead system, utilize off-the-shelf cameras to deliver precise depth sensing, targeting applications for level 3 and level 4 autonomous vehicles. This technology supports functions such as collision warning, path planning, and automatic emergency braking, contributing to improved safety and performance in the automotive sector.

Trevi Therapeutics

Post in 2022
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, dedicated to developing and commercializing nalbuphine ER, an investigational therapy. The company's lead product, Haduvio, is an oral extended-release formulation of nalbuphine currently undergoing Phase IIb/III clinical trials. Trevi Therapeutics is focused on addressing serious neurologically mediated conditions, including chronic pruritus, chronic cough associated with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in Parkinson's disease patients. The ongoing PRISM trial evaluates Haduvio's effectiveness in treating severe pruritus related to prurigo nodularis, highlighting its potential in managing conditions linked by a common pathophysiology involving opioid receptors in the nervous system. Founded in 2011, Trevi Therapeutics aims to provide innovative therapeutic solutions for patients with significant unmet medical needs.

ForAllSecure

Series B in 2022
ForAllSecure Inc. is a cybersecurity company focused on enhancing software security through advanced testing solutions. Established in 2012 and headquartered in Pittsburgh, Pennsylvania, with additional locations in Palo Alto, California, and Crystal City, Virginia, the company leverages patented technology developed from research at Carnegie Mellon University. Its primary product, Mayhem, is a fuzz testing solution that automates the detection of software defects at scale and integrates seamlessly into continuous integration pipelines, thereby streamlining security processes for organizations. ForAllSecure partners with Fortune 1000 companies across industries such as aerospace, automotive, and high-tech to provide scalable security testing that keeps pace with rapid development cycles. The company has received recognition for its innovative contributions to cybersecurity, including winning DARPA's Cyber Grand Challenge and being listed among the 50 Smartest Companies by MIT Technology Review.

Alfred

Venture Round in 2022
Alfred is an end-to-end resident experience and building management platform that is changing the way people live and transforming the real estate industry. Operating at the intersection of real estate and technology, Alfred builds intuitive, personal support into one of the most important spaces of our lives: our homes. Named one of the Top 50 Most Innovative Companies in the World by Fast Company in the urban development space, Alfred has been recognized in The New York Times, The Financial Times, and Wall Street Journal, as a pioneer in the on-demand economy, following their decision to hire Alfred Home Managers as W-2 employees (complete with benefits, training, and the ability to move up in the organization) and its support of local ecosystems and neighborhood businesses. Hello Alfred was founded in 2014 by Marcela Sapone and Jessica Beck, and is headquartered in New York, New York, United States.

Beyond Identity

Series C in 2022
Beyond Identity's mission is to empower the next generation of secure digital business by replacing passwords with fundamentally secure X.509-based certificates. This patent-pending approach creates an extended Chain of Trust that includes user and device identity and a real-time snapshot of the device’s security posture for adaptive risk-based authentication and authorization. Beyond Identity’s cloud-native solution enables customers to increase business velocity, implement new business models, reduce operating costs, and achieve complete passwordless identity management.

Timescale

Series C in 2022
Timescale, Inc. owns and operates data analysis platform for scale, ease of use, and complex queries. Its product includes TimescaleDB, which is an open source time-series database that supports full SQL; and Community, which is a software developed for time-series database optimized for advanced analytics and built for production use cases. Timescale, Inc. was formerly known as IoBeam. The company was incorporated in 2011 and is based in New York, New York with additional offices in Stockholm, Sweden and Los Angeles, California.

hOS

Seed Round in 2022
HOS is an AI technology company that develops scalable technologies to achieve significant and constructive changes in the world.

Neo Cybernetica

Seed Round in 2022
Neo Cybernetica specializes in the development of cybernetics technology aimed at enhancing the capabilities of artificial intelligence systems. By leveraging advanced communication and automatic control systems, the company focuses on creating AI systems that can operate independently as well as collaborate effectively with humans. This innovative approach positions Neo Cybernetica to address future opportunities and challenges, ultimately contributing to the advancement of AI technologies that can benefit society in the coming decades.

HackerOne

Series E in 2022
HackerOne, founded in 2012 and headquartered in San Francisco, develops a hacker-powered security platform that connects businesses with penetration testers and cybersecurity researchers. The platform offers various services, including bug bounty solutions and vulnerability disclosure programs, which help organizations identify and mitigate security risks before they can be exploited. By collaborating with a global community of ethical hackers, HackerOne assists companies in enhancing their vulnerability coordination processes, ultimately protecting consumer data and trust. With additional offices in London, New York City, Singapore, and the Netherlands, HackerOne plays a crucial role in facilitating communication between businesses and security experts to address relevant security issues effectively.

Proof of Learn

Seed Round in 2022
Proof of Learn (POL) is a blockchain start-up Web3 education platform.

Korro Bio

Series B in 2022
Korro Bio Inc. specializes in the development of nucleic acid-based therapeutics aimed at targeting specific sequences in genetic code, with a focus on treating rare diseases. Founded in 2018 and located in Cambridge, Massachusetts, the company utilizes a proprietary platform that enables efficient and selective RNA editing by leveraging natural processes found in multi-cellular organisms. This innovative approach allows Korro Bio to edit messenger RNA and recode specific codons, facilitating targeted modifications in protein structure and function across various tissues.

Belong Health

Series A in 2021
Belong Health is a health insurance company focused on delivering Medicare Advantage and special needs plan products. The company collaborates with local health plans to provide regionally informed and compassionate care to a growing community. By partnering with these regional health plans, Belong Health aims to create a straightforward Medicare experience for eligible members, facilitating access to quality healthcare through trusted insurance partners. This approach allows Belong Health to launch or enhance market-leading plans that address the specific needs of its members.

Wonder

Series A in 2021
Wonder is a gaming company focused on developing an all-in-one gaming platform specifically for Android mobile devices. The platform enables users to play, stream, and share games seamlessly across different devices, thereby enhancing the overall gaming experience. Additionally, Wonder is exploring VR-ready gaming hardware to further enrich its offerings. Currently, the company operates in stealth mode, indicating that it is in the early stages of development and not yet publicly available.

Block Renovation

Series C in 2021
Block Renovation is a renovation platform that combines architect-grade design, construction labor, and materials into a streamlined renovation experience. Block’s mission is to give homeowners a better way to improve the spaces they live in, and to give contractors a better way to work. Founded by Koda Wang and Luke Sherwin, Block simplifies a complex and convoluted process and delivers an intuitive experience for completing a beautiful home renovation.

Kiswe

Venture Round in 2021
Kiswe Mobile, Inc. is a media packaging and technology company that specializes in live media solutions for sports and entertainment content owners. Founded in 2013 and headquartered in New Providence, New Jersey, Kiswe develops an application that allows users to discover, direct, watch, clip, and share live videos from their smartphones. The company's flagship product, CloudCast, leverages cloud-based technology to enhance the production and broadcasting of live events. Kiswe's solutions are utilized by major broadcasters, media companies, sports and eSports leagues, and music labels, including notable clients such as BTS, the NBA, and the PGA Tour. With additional offices in Europe and Asia, Kiswe aims to connect at-home viewers with live events and in-venue fans through interactive video experiences that foster social engagement and loyalty.

Attest

Series B in 2021
Attest Technologies Ltd. is a consumer growth platform based in London, United Kingdom, with additional operations in New York. Founded in 2015, Attest specializes in providing insights through brand tracking, testing, international research, and product development solutions. The platform allows businesses to engage with over 100 million consumers across more than 45 countries, facilitating immediate access to dynamic data and insights. Attest caters to a diverse clientele, including enterprises and rapidly growing companies, empowering them to make informed decisions across various areas such as marketing, product development, and competitive analysis. By addressing critical growth challenges and filling knowledge gaps, Attest enables organizations to leverage consumer feedback effectively and adapt to market demands in real-time.

Candy

Series A in 2021
Candy is a multifaceted company that operates in the digital collectible and confectionery sectors. It develops sports and culture digital assets, providing authentic digital experiences that engage fans and connect them with their interests. Additionally, Candy.com serves as an online retailer catering to the growing demand for bulk, gourmet, and gift confectionery products, offering competitive pricing, expedited shipping, and a unique shopping experience. Furthermore, Candy Digital specializes in non-fungible tokens (NFTs), enabling fans to buy and trade officially licensed tokens related to Major League Baseball. Launched in 2021, this segment of the business was established by notable figures in the industry and reflects Candy's commitment to integrating technology with fan engagement.

Clarifai

Series C in 2021
Clarifai, Inc. specializes in advanced image recognition technology, allowing users to detect near-duplicates and conduct visual searches. The company's systems can identify various categories, objects, and tags within images, enabling the discovery of similar images in large, uncategorized repositories through a combination of semantic and visual similarity. Additionally, Clarifai offers Labeler, a tool designed for labeling unstructured datasets, facilitating data search using artificial intelligence, training AI models, and auto-scaling models in production. Founded in 2013, Clarifai is headquartered in New York, with an additional office in Tallinn, Estonia.

Wizard

Series A in 2021
Wizard is a software development company that offers B2B solutions for brands to sell and market products directly through text.

Pager

Series C in 2021
Pager, Inc. develops and operates an on-demand service platform that connects patients with healthcare in their home, office, and hotel. The company offers Pager, a location-based mobile application that connects users with care to treat their urgent care needs, including urinary tract infection, upper respiratory infection, strep throat, fever, bronchitis, influenza, cold, nausea, back pain, rashes, burns, allergy, asthma, and others. It also provides nurse chat, teleconsult, screening, vaccination, and prescription delivery services. The company was formerly known as techCare, Inc. and changed its name to Pager, Inc. in July, 2014. Pager, Inc. was incorporated in 2013 and is based in New York, New York.

Tulip Interfaces

Series C in 2021
Tulip Interfaces, Inc. is a company that specializes in developing applications for the manufacturing sector. Founded in 2012 and based in Somerville, Massachusetts, Tulip offers a Manufacturing App Platform that integrates data from various sources, including sensors, to create real-time digital work instructions and visualizations. This platform connects existing shop floor equipment with operator inputs, enhancing operational efficiency. Tulip's technology leverages advancements in intelligent hardware, computer vision, user interfaces, and machine learning, bridging the gap between traditional manufacturing IT systems and the dynamic needs of the shop floor. The company serves a diverse range of industries, including consumer electronics, pharmaceuticals, apparel, and medical devices, with its solutions deployed across multiple global customers.

Block Renovation

Series B in 2021
Block Renovation is a renovation platform that combines architect-grade design, construction labor, and materials into a streamlined renovation experience. Block’s mission is to give homeowners a better way to improve the spaces they live in, and to give contractors a better way to work. Founded by Koda Wang and Luke Sherwin, Block simplifies a complex and convoluted process and delivers an intuitive experience for completing a beautiful home renovation.

Aetion

Series C in 2021
Aetion, Inc. develops a science and analytics platform to assess real-world evidence (RWE) from a range of sources. The company offers Aetion Evidence Platform, a platform that generates RWE needed by healthcare decision makers to engage in value-based care. Its solution allows payers, providers, medical device makers, biopharma customers, and academic institutions to analyze data from various clinical and financial interactions in healthcare, including claims, electronic health records, registries, and clinical trials. The company’s platform is also used in database analytics and comparative effectiveness courses taken by epidemiologists, outcomes researchers, health economists, and biostatisticians. It serves customers worldwide. Aetion, Inc. has a strategic collaboration with McKesson. The company was founded in 2012 and is based in New York, New York.

Timescale

Series B in 2021
Timescale, Inc. owns and operates data analysis platform for scale, ease of use, and complex queries. Its product includes TimescaleDB, which is an open source time-series database that supports full SQL; and Community, which is a software developed for time-series database optimized for advanced analytics and built for production use cases. Timescale, Inc. was formerly known as IoBeam. The company was incorporated in 2011 and is based in New York, New York with additional offices in Stockholm, Sweden and Los Angeles, California.

Affinia Therapeutics

Series B in 2021
Affinia Therapeutics Inc. is a biotechnology company focused on developing gene therapies for various diseases, particularly those affecting muscle and the central nervous system (CNS). Founded in 2019 and based in Waltham, Massachusetts, the company specializes in creating rationally designed adeno-associated virus (AAV) vectors. By integrating synthetic and systems biology with high-throughput screening and advanced resolution techniques, Affinia Therapeutics aims to address significant unmet medical needs. The company’s innovative approach allows for the development of novel gene therapies with enhanced properties, targeting the treatment of devastating diseases and improving the lives of affected individuals.

Code Biotherapeutics

Seed Round in 2021
Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. Code Bio leverages its novel multivalent synthetic DNA delivery platform, 3DNA, which has been engineered to overcome many of the challenges inherent with viral-based gene therapies such as immunogenicity, size and delivery limitations, re-dosability, and manufacturing complexity. The Company is advancing an internal pipeline focused on select rare disease programs as well as establishing partnerships to take forward programs in both rare and prevalent diseases.

Plaid

Series D in 2021
Plaid Inc. is a technology platform that enables users to connect their bank accounts to various applications, aiming to democratize financial services through innovative solutions. Founded in 2012 and based in San Francisco, Plaid provides a suite of APIs that allow developers to create financial products that connect consumers with traditional financial institutions. Its offerings include tools for accessing transaction history, authenticating bank accounts, verifying identities, and checking real-time account balances and income. These products are utilized across various sectors, including personal finance, consumer payments, lending, banking, and brokerage. Plaid serves a wide range of clients, from startups to Fortune 50 companies, facilitating the development of modern financial services and applications.

Spokn

Seed Round in 2021
Spokn helps companies develop their talent and build a culture of continuous learning - all in audio. Our 'bite-sized' insights cover skills like communication, collaboration, productivity and leadership and come from the top experts in the world - from Harvard Business School and MIT to HubSpot, Mindful, the Financial Times and more. The best part? It's 100% in audio, so learning fits into the daily routine of employees.

Spokn

Seed Round in 2021
Spokn helps companies develop their talent and build a culture of continuous learning - all in audio. Our 'bite-sized' insights cover skills like communication, collaboration, productivity and leadership and come from the top experts in the world - from Harvard Business School and MIT to HubSpot, Mindful, the Financial Times and more. The best part? It's 100% in audio, so learning fits into the daily routine of employees.

Nuvolo

Series C in 2021
Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform built on the ServiceNow framework. Established in 2013 and headquartered in Paramus, New Jersey, with additional offices in London, Bulgaria, and India, Nuvolo specializes in life-cycle management solutions for assets in clinics, laboratories, facilities, and manufacturing sectors. The company provides a comprehensive suite of services that includes implementation, support, tracking, reporting, and analytics, aimed at enhancing the user experience for mobile and remote workforces. Known for its commitment to innovation and customer service, Nuvolo has formed strategic partnerships with major firms such as Atos, KPMG, and Unisys to further its mission of becoming a leader in cloud-based enterprise asset management.

Burrow

Series C in 2021
Burrow, Inc. is a furniture design and manufacturing company based in New York, founded in 2016. It specializes in creating luxury furniture for homes, offering a diverse range of products including sofas, sectionals, sleepers, loveseats, armchairs, and ottomans, as well as tables, rugs, and various accessories like pillows and throws. The furniture is handcrafted from sustainably-sourced hardwood and features non-toxic, scratch- and stain-resistant fabrics. Burrow sells its products through physical showrooms located in several states, including Washington, Massachusetts, Texas, and California, as well as online. The company also operates a manufacturing facility in Mexico City, Mexico.

Dandelion Energy

Series B in 2021
Dandelion Energy offers affordable geothermal heating and cooling installations. Dandelion Energy's home geothermal system replaces your home’s existing air conditioning and heating equipment with a powerful heat pump and safe, underground pipes that move heat between the earth and home. Kathleen Hannun and Rajeez Quazi founded it in 2017, with its headquarters in Palo Alto in California.

Narmi

Series A in 2021
Narmi Inc. is a technology company that specializes in developing online and mobile banking applications for regional and community financial institutions in the United States. Founded in 2016 and headquartered in New York City, Narmi aims to enhance the banking experience by providing a platform that allows these institutions to attract, engage, and retain customers more effectively. Their offerings include features such as online banking, account opening with fraud protection, and multi-factor authentication, all designed to streamline financial transactions and improve customer interaction. By equipping regional and community banks with advanced technology, Narmi helps them compete against larger banks and FinTech companies, fostering a more diverse and engaging financial ecosystem. In addition to its banking applications, Narmi also provides website design, development, and hosting services, as well as content generation and management solutions.

New Wave Foods

Series A in 2021
New Wave Foods, Inc. specializes in producing and selling plant-based seafood products, focusing primarily on sustainable shrimp alternatives. Founded in 2015 and headquartered in San Francisco, California, the company offers a variety of items, including sautéed, grilled, breaded, and fried shrimp, as well as shrimp tacos and salads. Its products are made from sustainably sourced seaweed and soy protein, enriched with natural flavors and essential amino acids, providing a healthy, low-calorie, and zero-cholesterol option for consumers. Targeting the culinary market in the United States, New Wave Foods aims to preserve and enrich seafood traditions through its innovative plant-based offerings.

Beyond Identity

Series B in 2020
Beyond Identity's mission is to empower the next generation of secure digital business by replacing passwords with fundamentally secure X.509-based certificates. This patent-pending approach creates an extended Chain of Trust that includes user and device identity and a real-time snapshot of the device’s security posture for adaptive risk-based authentication and authorization. Beyond Identity’s cloud-native solution enables customers to increase business velocity, implement new business models, reduce operating costs, and achieve complete passwordless identity management.

DataRobot

Series F in 2020
DataRobot, Inc. develops an automated machine learning platform designed to help enterprises build predictive models efficiently. The company's offerings include DataRobot Cloud, a predictive analytics platform available on-site or via the cloud, and DataRobot MLOps, which focuses on the deployment, monitoring, and management of machine learning models within organizations. Additionally, DataRobot Enterprise provides features such as flexible deployment, governance, and support, along with packages aimed at accelerating artificial intelligence projects and education services. The platform is suitable for a diverse range of professionals, including business analysts, data scientists, and IT specialists across various industries like banking, healthcare, and marketing. Founded in 2012 and headquartered in Boston, Massachusetts, DataRobot also maintains operations in several international locations, including London, Paris, Kyiv, Tokyo, and Singapore. The company has established strategic partnerships to enhance its offerings in the competitive AI landscape.

Alfred

Series C in 2020
Alfred is an end-to-end resident experience and building management platform that is changing the way people live and transforming the real estate industry. Operating at the intersection of real estate and technology, Alfred builds intuitive, personal support into one of the most important spaces of our lives: our homes. Named one of the Top 50 Most Innovative Companies in the World by Fast Company in the urban development space, Alfred has been recognized in The New York Times, The Financial Times, and Wall Street Journal, as a pioneer in the on-demand economy, following their decision to hire Alfred Home Managers as W-2 employees (complete with benefits, training, and the ability to move up in the organization) and its support of local ecosystems and neighborhood businesses. Hello Alfred was founded in 2014 by Marcela Sapone and Jessica Beck, and is headquartered in New York, New York, United States.

Illusive

Series B in 2020
Illusive Networks Ltd. specializes in cybersecurity solutions that utilize deception technology to protect organizations from advanced cyber threats. The company offers a range of services, including compliance support, insider threat defense, and cloud security solutions. Their product suite includes the Illusive Networks Management Platform for centralized cyber security management, the Attack Surface Manager for continuous network vulnerability discovery, and tools for attack detection and intelligence that provide actionable insights into cyber incidents. Illusive Networks serves various industries, including financial services, healthcare, legal, manufacturing, retail, and technology. Founded in 2014, the company operates from its headquarters in Tel Aviv-Yafo, Israel, and has an additional office in New York, New York.

Korro Bio

Series A in 2020
Korro Bio Inc. specializes in the development of nucleic acid-based therapeutics aimed at targeting specific sequences in genetic code, with a focus on treating rare diseases. Founded in 2018 and located in Cambridge, Massachusetts, the company utilizes a proprietary platform that enables efficient and selective RNA editing by leveraging natural processes found in multi-cellular organisms. This innovative approach allows Korro Bio to edit messenger RNA and recode specific codons, facilitating targeted modifications in protein structure and function across various tissues.

Maisonette

Series B in 2020
Maisonette Inc. operates an online marketplace specializing in baby and child products. Founded in 2016 and headquartered in Brooklyn, New York, the company curates a selection of high-quality children's items sourced from renowned designer brands and unique boutiques worldwide. By focusing on an expertly curated shopping experience, Maisonette aims to provide a superior platform for both consumers seeking premium children's products and smaller retailers looking to reach a broader audience.

Attest

Venture Round in 2020
Attest Technologies Ltd. is a consumer growth platform based in London, United Kingdom, with additional operations in New York. Founded in 2015, Attest specializes in providing insights through brand tracking, testing, international research, and product development solutions. The platform allows businesses to engage with over 100 million consumers across more than 45 countries, facilitating immediate access to dynamic data and insights. Attest caters to a diverse clientele, including enterprises and rapidly growing companies, empowering them to make informed decisions across various areas such as marketing, product development, and competitive analysis. By addressing critical growth challenges and filling knowledge gaps, Attest enables organizations to leverage consumer feedback effectively and adapt to market demands in real-time.

Beyond Identity

Series A in 2020
Beyond Identity's mission is to empower the next generation of secure digital business by replacing passwords with fundamentally secure X.509-based certificates. This patent-pending approach creates an extended Chain of Trust that includes user and device identity and a real-time snapshot of the device’s security posture for adaptive risk-based authentication and authorization. Beyond Identity’s cloud-native solution enables customers to increase business velocity, implement new business models, reduce operating costs, and achieve complete passwordless identity management.

Affinia Therapeutics

Series A in 2020
Affinia Therapeutics Inc. is a biotechnology company focused on developing gene therapies for various diseases, particularly those affecting muscle and the central nervous system (CNS). Founded in 2019 and based in Waltham, Massachusetts, the company specializes in creating rationally designed adeno-associated virus (AAV) vectors. By integrating synthetic and systems biology with high-throughput screening and advanced resolution techniques, Affinia Therapeutics aims to address significant unmet medical needs. The company’s innovative approach allows for the development of novel gene therapies with enhanced properties, targeting the treatment of devastating diseases and improving the lives of affected individuals.

Pager

Series B in 2020
Pager, Inc. develops and operates an on-demand service platform that connects patients with healthcare in their home, office, and hotel. The company offers Pager, a location-based mobile application that connects users with care to treat their urgent care needs, including urinary tract infection, upper respiratory infection, strep throat, fever, bronchitis, influenza, cold, nausea, back pain, rashes, burns, allergy, asthma, and others. It also provides nurse chat, teleconsult, screening, vaccination, and prescription delivery services. The company was formerly known as techCare, Inc. and changed its name to Pager, Inc. in July, 2014. Pager, Inc. was incorporated in 2013 and is based in New York, New York.

Akouos

Series B in 2020
Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.

Moda Operandi

Venture Round in 2020
Moda Operandi, Inc. is an online retailer specializing in fashion products, including clothing, shoes, bags, jewelry, and home goods for men, women, and children. The company features an e-commerce platform that connects consumers with both established and emerging fashion designers worldwide. It offers unique shopping experiences through online designer trunk shows, allowing customers to preorder items directly from designers. Moda Operandi boasts a diverse portfolio of over 1,000 designers and maintains a global network of physical showrooms and personal stylists. The company ships products to more than 125 countries, enhancing its international reach. Founded in 2010 and headquartered in New York, Moda Operandi was initially named Trunk Show Inc. before rebranding in August 2010.

Moda Operandi

Debt Financing in 2020
Moda Operandi, Inc. is an online retailer specializing in fashion products, including clothing, shoes, bags, jewelry, and home goods for men, women, and children. The company features an e-commerce platform that connects consumers with both established and emerging fashion designers worldwide. It offers unique shopping experiences through online designer trunk shows, allowing customers to preorder items directly from designers. Moda Operandi boasts a diverse portfolio of over 1,000 designers and maintains a global network of physical showrooms and personal stylists. The company ships products to more than 125 countries, enhancing its international reach. Founded in 2010 and headquartered in New York, Moda Operandi was initially named Trunk Show Inc. before rebranding in August 2010.

Berkshire Grey

Series B in 2020
Berkshire Grey, Inc. specializes in developing artificial intelligence-driven robotic and automated material handling systems aimed at enhancing omnichannel fulfillment. Founded in 2013 and based in Lexington, Massachusetts, the company offers a range of solutions, including AI software, robotic arms, mobile robotic systems, and advanced sorting technologies. Its systems leverage artificial intelligence, computer vision, and machine learning to automate tasks traditionally performed by humans, thereby increasing accuracy and throughput in logistics and supply chain operations. Berkshire Grey's technology is designed to handle diverse products and packaging types, providing a significant competitive advantage to its customers. The company primarily generates its revenue from North America and operates as a subsidiary of SoftBank Group Corp.

Dandelion Energy

Series A in 2020
Dandelion Energy offers affordable geothermal heating and cooling installations. Dandelion Energy's home geothermal system replaces your home’s existing air conditioning and heating equipment with a powerful heat pump and safe, underground pipes that move heat between the earth and home. Kathleen Hannun and Rajeez Quazi founded it in 2017, with its headquarters in Palo Alto in California.
Black Diamond Therapeutics is a precision oncology medicine company focused on discovering and developing small molecule, tumor-agnostic therapies. The company's lead product candidate, BDTX-189, is designed to inhibit specific mutations in ErbB kinases, including the epidermal growth factor receptor. Additionally, Black Diamond is advancing a pipeline of allosteric-EGFR mutation inhibitors and other early-stage programs targeting allosteric mutations in kinases associated with cancer and rare genetic diseases. The company employs a technology platform known as Mutation-Allostery-Pharmacology, which aims to address undrugged mutations in patients with genetically defined cancers. Founded in 2014 and based in Cambridge, Massachusetts, Black Diamond Therapeutics was previously known as ASET Therapeutics until its rebranding in 2018.

Flow Commerce

Series B in 2019
Flow provides a turn-key platform for e-commerce companies to go global, capturing international demand for their products. The platform enables merchants to simply configure their cross-border supply-chain requirements and immediately fulfill their overseas demand. Flow can be used by e-commerce companies of any size and both as a complete, end-to-end solution or as a modular unbundled product. Using the Flow platform the experience of buying and selling internationally is as easy as domestic for both merchants and consumers.

Neural Magic

Seed Round in 2019
Neural Magic is unlocking the possibility of machine learning, by re-imagining how deep learning is done. A team of pioneers, we believe machine learning has the potential to alter the trajectory of human history. Break free of limitations. Be a part of the future.

Neural Magic

Seed Round in 2019
Neural Magic is unlocking the possibility of machine learning, by re-imagining how deep learning is done. A team of pioneers, we believe machine learning has the potential to alter the trajectory of human history. Break free of limitations. Be a part of the future.

The Yes

Series A in 2019
They are co-located in Silicon Valley and New York City, but are open to great talent anywhere. They welcome critical thinkers who are excited to re-write the rules of e-commerce. They promise it will be fun.

DataRobot

Series E in 2019
DataRobot, Inc. develops an automated machine learning platform designed to help enterprises build predictive models efficiently. The company's offerings include DataRobot Cloud, a predictive analytics platform available on-site or via the cloud, and DataRobot MLOps, which focuses on the deployment, monitoring, and management of machine learning models within organizations. Additionally, DataRobot Enterprise provides features such as flexible deployment, governance, and support, along with packages aimed at accelerating artificial intelligence projects and education services. The platform is suitable for a diverse range of professionals, including business analysts, data scientists, and IT specialists across various industries like banking, healthcare, and marketing. Founded in 2012 and headquartered in Boston, Massachusetts, DataRobot also maintains operations in several international locations, including London, Paris, Kyiv, Tokyo, and Singapore. The company has established strategic partnerships to enhance its offerings in the competitive AI landscape.

HackerOne

Series D in 2019
HackerOne, founded in 2012 and headquartered in San Francisco, develops a hacker-powered security platform that connects businesses with penetration testers and cybersecurity researchers. The platform offers various services, including bug bounty solutions and vulnerability disclosure programs, which help organizations identify and mitigate security risks before they can be exploited. By collaborating with a global community of ethical hackers, HackerOne assists companies in enhancing their vulnerability coordination processes, ultimately protecting consumer data and trust. With additional offices in London, New York City, Singapore, and the Netherlands, HackerOne plays a crucial role in facilitating communication between businesses and security experts to address relevant security issues effectively.

Burrow

Series B in 2019
Burrow, Inc. is a furniture design and manufacturing company based in New York, founded in 2016. It specializes in creating luxury furniture for homes, offering a diverse range of products including sofas, sectionals, sleepers, loveseats, armchairs, and ottomans, as well as tables, rugs, and various accessories like pillows and throws. The furniture is handcrafted from sustainably-sourced hardwood and features non-toxic, scratch- and stain-resistant fabrics. Burrow sells its products through physical showrooms located in several states, including Washington, Massachusetts, Texas, and California, as well as online. The company also operates a manufacturing facility in Mexico City, Mexico.

Heap

Series C in 2019
Heap Inc. develops an analytics infrastructure designed for online businesses, enabling them to capture and analyze web, mobile, and cloud interactions, such as clicks and transactions. Founded in 2012 and headquartered in San Francisco, California, with additional offices in New York and Utah, Heap's solution automates the analytics process, allowing companies to focus on deriving insights and making informed business decisions. The platform provides a comprehensive view of customer data, helping businesses optimize product offerings and enhance user experiences. Heap serves over 6,000 clients across various industries, including e-commerce, financial services, and software as a service (SaaS), with notable customers such as Twilio, LendingClub, and Optimizely.

Nuvolo

Series B in 2019
Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform built on the ServiceNow framework. Established in 2013 and headquartered in Paramus, New Jersey, with additional offices in London, Bulgaria, and India, Nuvolo specializes in life-cycle management solutions for assets in clinics, laboratories, facilities, and manufacturing sectors. The company provides a comprehensive suite of services that includes implementation, support, tracking, reporting, and analytics, aimed at enhancing the user experience for mobile and remote workforces. Known for its commitment to innovation and customer service, Nuvolo has formed strategic partnerships with major firms such as Atos, KPMG, and Unisys to further its mission of becoming a leader in cloud-based enterprise asset management.

Tamara Mellon

Series C in 2019
Tamara Mellon, LLC offers apparel and accessories for women. It offers shoes, including sandals, boots, pumps, flats, and legging boots; bags and accessories; and ready to wear solutions, such as dresses, jumpsuits and rompers, tops and knitwear, pants and skirts, and jackets and outerwear. The company sells its products through retail and online stores in the United States and internationally. Tamara Mellon, LLC was incorporated in 2011 and is headquartered in New York, New York.

Block Renovation

Series A in 2019
Block Renovation is a renovation platform that combines architect-grade design, construction labor, and materials into a streamlined renovation experience. Block’s mission is to give homeowners a better way to improve the spaces they live in, and to give contractors a better way to work. Founded by Koda Wang and Luke Sherwin, Block simplifies a complex and convoluted process and delivers an intuitive experience for completing a beautiful home renovation.

Intact Vascular

Series D in 2019
Intact Vascular, Inc., a medical device company, develops medical devices for minimally invasive peripheral vascular procedures. The company offers Tack Endovascular System, a device that offers optimization of peripheral balloon angioplasty results during the treatment of peripheral arterial disease (PAD) and critical limb ischemia (CLI). Intact Vascular, Inc. was formerly known as Tackit Vascular LLC. The company was founded in 2011 and is based in Wayne, Pennsylvania.

Vesper Medical

Venture Round in 2019
Vesper Medical, Inc., a medical device company, develops minimally invasive peripheral vascular products. It offer Vesper DUO Venous Stent System, built for venous stenting. The company was founded in 2016 and is based in Wayne, Pennsylvania.

Mejuri

Series B in 2019
Mejuri Inc. manufactures and sells fine jewelry. The company offers products in various categories, including rings, necklaces, earrings, bracelets and anklets, and engagement. It offers products through its showrooms, as well as online to customers in the United States, Canada, and internationally. The company was founded in 1953 and is based in Toronto, Canada. It has showrooms in New York, New York; Toronto, Canada; and Chicago, Illinois.

THE WELL

Series A in 2019
THE WELL is a modern membership-based wellness club designed for busy urban professionals. They bring together Western doctors and Eastern healers to collaborate, developing online content and personalized products and experiences that empower their community to take greater agency for their health. The company recognizes both the benefits of Western medicine and the wisdom of Eastern healing and have built a science-backed ecosystem for wellness. The Well's integrative medicine doctors, health coaches, and skilled practitioners work together under one roof to build customized plans uniquely suited to each member and their goals.

Barricaid

Series E in 2019
Intrinsic Therapeutics, Inc. develops and manufactures medical devices aimed at treating lumbar disc herniations, primarily under the trade name Barricaid. The company specializes in creating anular prostheses for partial replacement following discectomy surgery, as well as an anular closure device designed to prevent reherniations in patients with anular defects. Barricaid enables the reconstruction of weakened and ruptured spinal tissues, addressing issues related to sciatica and low back pain. Intrinsic Therapeutics serves both surgeons and patients and distributes its products across various countries, including Germany, Austria, Australia, and several others in Europe and Latin America. Founded in 2000 and based in Woburn, Massachusetts, the company also maintains offices in Oirschot, The Netherlands, and Düsseldorf, Germany.

Inozyme

Series A in 2019
Inozyme Pharma, Inc. is a biopharmaceutical company focused on developing therapies for rare diseases related to abnormal mineralization affecting the vasculature, soft tissue, and skeletal systems. The company's lead product candidate, INZ-701, is a recombinant protein designed to treat rare genetic conditions caused by ENPP1 and ABCC6 deficiencies, as well as calciphylaxis. Inozyme's therapies aim to address the underlying causes of these debilitating diseases, providing potentially disease-modifying treatments for conditions such as Generalized Arterial Calcification of Infancy and Autosomal Recessive Hypophosphatemic Rickets Type 2. The company has a licensing agreement with Yale University for certain therapeutic applications and is headquartered in Boston, Massachusetts. Established in 2015, Inozyme is dedicated to improving the quality of life for patients affected by severe metabolic disorders associated with mineral imbalances.

Attest

Series A in 2019
Attest Technologies Ltd. is a consumer growth platform based in London, United Kingdom, with additional operations in New York. Founded in 2015, Attest specializes in providing insights through brand tracking, testing, international research, and product development solutions. The platform allows businesses to engage with over 100 million consumers across more than 45 countries, facilitating immediate access to dynamic data and insights. Attest caters to a diverse clientele, including enterprises and rapidly growing companies, empowering them to make informed decisions across various areas such as marketing, product development, and competitive analysis. By addressing critical growth challenges and filling knowledge gaps, Attest enables organizations to leverage consumer feedback effectively and adapt to market demands in real-time.

Casper

Series D in 2019
Casper Sleep Inc. is a company that designs and sells a variety of sleep products, including mattresses, pillows, sheets, duvets, and sleep accessories, to consumers in the United States, Canada, and Europe. Originally founded in 2013 as Providence Mattress Company, the business rebranded in 2014 and has since developed its products in-house by leveraging the expertise of product engineers. Casper aims to provide quality sleep solutions by selling directly to consumers through its e-commerce platform, 60 retail stores, and various retail partners, thereby eliminating inflated prices associated with commission-driven sales. In addition to its core offerings, Casper has expanded its product line to include bedroom furniture and sleep technology, catering to a diverse range of customer needs. The company is headquartered in New York, New York.

Imara

Series B in 2019
Imara, Inc. is a clinical-stage biopharmaceutical company based in Boston, Massachusetts, focused on developing innovative therapeutics for patients with rare genetic disorders of hemoglobin, particularly sickle cell disease and beta-thalassemia. Founded in 2016, the company is advancing IMR-687, a once-daily oral therapy designed to be a potent small molecule inhibitor of PDE9. This therapeutic aims to address the significant health challenges associated with these conditions, which can lead to reduced healthy red blood cells and various complications. Imara was established following a collaboration between Cydan Development and H. Lundbeck A/S, with initial funding from notable life science investors.

Luminary Media

Venture Round in 2019
Luminary Media, LLC is a subscription-based audio entertainment service that specializes in podcasts. Founded in 2018, the company is focused on creating a comprehensive podcast ecosystem that connects listeners with a diverse range of creators, including entertainers and thought leaders. Luminary Media distinguishes itself by offering a wide selection of shows and original content without advertisements, enhancing the listening experience for its users. With a commitment to innovation and design, Luminary aims to inform, educate, and entertain its audience, positioning itself as a significant player in the podcasting industry. The company is headquartered in New York, New York.

Oyster Point Pharma I

Series B in 2019
Oyster Point Pharma, Inc. is a clinical-stage biopharmaceutical company based in Princeton, New Jersey, that specializes in the discovery, development, and commercialization of innovative therapies for ocular surface diseases. Founded in 2015, the company is primarily focused on its lead product candidate, OC-01, a nicotinic acetylcholine receptor agonist currently undergoing Phase III clinical trials for the treatment of dry eye disease. This condition, which affects over 30 million Americans, is characterized by a chronic lack of sufficient tears, leading to discomfort and potential vision problems. OC-01 is developed as a nasal spray and aims to restore tear film homeostasis by activating the trigeminal parasympathetic pathway, thereby stimulating natural tear production. Additionally, the company is exploring the use of OC-01 for neurotrophic keratitis, further expanding its therapeutic potential in ocular health.

Landit

Series A in 2019
Landit is a technology platform that increases the success and engagement of women and diverse groups in the workplace. The market leader in personalized career pathing, Landit creates a turnkey “one size fits one” solution that enables enterprises to attract, develop, and retain high-potential diverse talent. Landit provides each member with a personalized playbook that empowers them with the tools, resources, know-how, and human connections they need to advance and navigate their career path. Key features include building a personal brand, executive coaching, creating a personal board of advisors, curated skill development and mapping to career opportunities.

Tulip Interfaces

Series B in 2019
Tulip Interfaces, Inc. is a company that specializes in developing applications for the manufacturing sector. Founded in 2012 and based in Somerville, Massachusetts, Tulip offers a Manufacturing App Platform that integrates data from various sources, including sensors, to create real-time digital work instructions and visualizations. This platform connects existing shop floor equipment with operator inputs, enhancing operational efficiency. Tulip's technology leverages advancements in intelligent hardware, computer vision, user interfaces, and machine learning, bridging the gap between traditional manufacturing IT systems and the dynamic needs of the shop floor. The company serves a diverse range of industries, including consumer electronics, pharmaceuticals, apparel, and medical devices, with its solutions deployed across multiple global customers.

Dandelion Energy

Series A in 2019
Dandelion Energy offers affordable geothermal heating and cooling installations. Dandelion Energy's home geothermal system replaces your home’s existing air conditioning and heating equipment with a powerful heat pump and safe, underground pipes that move heat between the earth and home. Kathleen Hannun and Rajeez Quazi founded it in 2017, with its headquarters in Palo Alto in California.

Dandelion

Series A in 2019
Dandelion's vision is to enable frictionless discovery of content and commerce. In a world where its easy for anyone to be a seller, it should be easy for anyone to be a marketer too. Dandelion provides the platform to storefronts, marketplaces, and their participants to make that happen.

Aetion

Series B in 2019
Aetion, Inc. develops a science and analytics platform to assess real-world evidence (RWE) from a range of sources. The company offers Aetion Evidence Platform, a platform that generates RWE needed by healthcare decision makers to engage in value-based care. Its solution allows payers, providers, medical device makers, biopharma customers, and academic institutions to analyze data from various clinical and financial interactions in healthcare, including claims, electronic health records, registries, and clinical trials. The company’s platform is also used in database analytics and comparative effectiveness courses taken by epidemiologists, outcomes researchers, health economists, and biostatisticians. It serves customers worldwide. Aetion, Inc. has a strategic collaboration with McKesson. The company was founded in 2012 and is based in New York, New York.

Timescale

Series A in 2019
Timescale, Inc. owns and operates data analysis platform for scale, ease of use, and complex queries. Its product includes TimescaleDB, which is an open source time-series database that supports full SQL; and Community, which is a software developed for time-series database optimized for advanced analytics and built for production use cases. Timescale, Inc. was formerly known as IoBeam. The company was incorporated in 2011 and is based in New York, New York with additional offices in Stockholm, Sweden and Los Angeles, California.

Knotch

Series B in 2019
Knotch, Inc. is an independent provider of real-time intelligence focused on digital marketing. Founded in 2012 and based in San Francisco, Knotch offers a software-as-a-service (SaaS) platform that enables brands to connect their content to specific business outcomes. The Knotch intelligence suite equips marketers with the tools needed to access performance data and consumer sentiment insights, allowing for comprehensive analysis and optimization of content strategies. By providing metrics, benchmarks, and insights, Knotch supports brands in planning, measuring, and enhancing their marketing efforts across both owned and paid channels.
Black Diamond Therapeutics is a precision oncology medicine company focused on discovering and developing small molecule, tumor-agnostic therapies. The company's lead product candidate, BDTX-189, is designed to inhibit specific mutations in ErbB kinases, including the epidermal growth factor receptor. Additionally, Black Diamond is advancing a pipeline of allosteric-EGFR mutation inhibitors and other early-stage programs targeting allosteric mutations in kinases associated with cancer and rare genetic diseases. The company employs a technology platform known as Mutation-Allostery-Pharmacology, which aims to address undrugged mutations in patients with genetically defined cancers. Founded in 2014 and based in Cambridge, Massachusetts, Black Diamond Therapeutics was previously known as ASET Therapeutics until its rebranding in 2018.

Tiburio Therapeutics

Series A in 2019
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.The company's compounds aid in the treatment of non-functioning pituitary adenoma using a dopamine-somatostatin chimeric molecule that has the potential to shrink or halt tumor growth, providing patients with effective treatment for rare neuroendocrine tumors and endocrine diseases.

Trevi Therapeutics

Series C in 2019
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, dedicated to developing and commercializing nalbuphine ER, an investigational therapy. The company's lead product, Haduvio, is an oral extended-release formulation of nalbuphine currently undergoing Phase IIb/III clinical trials. Trevi Therapeutics is focused on addressing serious neurologically mediated conditions, including chronic pruritus, chronic cough associated with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in Parkinson's disease patients. The ongoing PRISM trial evaluates Haduvio's effectiveness in treating severe pruritus related to prurigo nodularis, highlighting its potential in managing conditions linked by a common pathophysiology involving opioid receptors in the nervous system. Founded in 2011, Trevi Therapeutics aims to provide innovative therapeutic solutions for patients with significant unmet medical needs.

The Wing

Series C in 2018
The Wing is a network of work and community spaces designed for women with locations in New York, California, and Washington, D.C. The Wing’s mission is the professional, civic, social, and economic advancement of women through the community.

Transfix

Series D in 2018
Transfix, Inc. is a prominent trucking brokerage service provider based in New York, offering digital solutions for freight transportation in the United States. Established in 2010, the company has developed an application that connects shippers with a network of contracted carriers, enabling real-time shipment tracking and performance insights. Transfix serves various industries, including retail, food, beverage, and manufacturing, delivering competitive pricing and reliable service. By leveraging deep industry knowledge and advanced logistics software, Transfix aims to optimize supply chains for its clients. The company has gained recognition for its innovative approach, with notable partnerships that include several top retailers and major food and beverage brands in America.

Block Renovation

Seed Round in 2018
Block Renovation is a renovation platform that combines architect-grade design, construction labor, and materials into a streamlined renovation experience. Block’s mission is to give homeowners a better way to improve the spaces they live in, and to give contractors a better way to work. Founded by Koda Wang and Luke Sherwin, Block simplifies a complex and convoluted process and delivers an intuitive experience for completing a beautiful home renovation.

Plaid

Series C in 2018
Plaid Inc. is a technology platform that enables users to connect their bank accounts to various applications, aiming to democratize financial services through innovative solutions. Founded in 2012 and based in San Francisco, Plaid provides a suite of APIs that allow developers to create financial products that connect consumers with traditional financial institutions. Its offerings include tools for accessing transaction history, authenticating bank accounts, verifying identities, and checking real-time account balances and income. These products are utilized across various sectors, including personal finance, consumer payments, lending, banking, and brokerage. Plaid serves a wide range of clients, from startups to Fortune 50 companies, facilitating the development of modern financial services and applications.

DataRobot

Series D in 2018
DataRobot, Inc. develops an automated machine learning platform designed to help enterprises build predictive models efficiently. The company's offerings include DataRobot Cloud, a predictive analytics platform available on-site or via the cloud, and DataRobot MLOps, which focuses on the deployment, monitoring, and management of machine learning models within organizations. Additionally, DataRobot Enterprise provides features such as flexible deployment, governance, and support, along with packages aimed at accelerating artificial intelligence projects and education services. The platform is suitable for a diverse range of professionals, including business analysts, data scientists, and IT specialists across various industries like banking, healthcare, and marketing. Founded in 2012 and headquartered in Boston, Massachusetts, DataRobot also maintains operations in several international locations, including London, Paris, Kyiv, Tokyo, and Singapore. The company has established strategic partnerships to enhance its offerings in the competitive AI landscape.

Forter

Series D in 2018
Forter, Inc. specializes in providing comprehensive e-commerce fraud prevention solutions for online merchants. Founded in 2013 and headquartered in New York, with additional offices in London and a research facility in Tel Aviv, the company offers a Decision-As-a-Service platform that utilizes a variety of data points, including cyber intelligence and behavioral analysis, to assess transactions. This system allows merchants to make informed fraud decisions with a transparent view provided through the Forter Decision Dashboard. Additionally, Forter Smart Routing enhances the payment process by preventing revenue loss from false declines. The platform is fully automated, focusing on creating a fraud-free environment that not only blocks fraudulent activities but also improves customer experience and transaction approvals. Forter aims to streamline risk management for e-commerce businesses, ensuring a secure and efficient transaction process.

Galera Therapeutics

Series C in 2018
Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics that aim to enhance the effectiveness of radiotherapy in cancer treatment. The company’s lead product candidate, avasopasem manganese (GC4419), is a small molecule mimetic of superoxide dismutase designed to address radiation-induced severe oral mucositis in patients with head and neck cancer. It is currently undergoing Phase III clinical trials for this indication and Phase IIa trials for treating radiotherapy-induced esophagitis in lung cancer patients. Additionally, Galera is developing a second candidate, GC4711, which is in Phase I/II trials for pancreatic and lung cancers. Founded in 2012 and headquartered in Malvern, Pennsylvania, Galera Therapeutics is dedicated to transforming cancer treatment through advancements in oxygen metabolic pathways.

Enigma

Series C in 2018
Enigma Technologies, Inc. is a New York-based operational data management and intelligence company that offers a comprehensive searchable database of public records and documents. Its core offerings include Enigma Data Infrastructure, which encompasses tools for data operations and search capabilities, and Enigma Solutions, tailored products and services for industries such as financial services, healthcare, and insurance. The company provides analysis-ready public data and operates Enigma Labs to develop open data tools for public use. Additionally, Enigma offers an application programming interface (API) to facilitate application development and various data services, including entity resolution and custom data acquisition. By delivering timely and accurate insights into small businesses' identities and risk profiles, Enigma supports organizations like American Express and PayPal in making informed operational decisions. Founded in 2011, Enigma continues to bridge the gap between data and workflows, enhancing decision-making processes across sectors.

PhaseBio

Series D in 2018
PhaseBio Pharmaceuticals is a clinical-stage biopharmaceutical company based in Malvern, Pennsylvania, focused on developing innovative therapies for cardiopulmonary diseases. Its lead product candidate, PB2452, is a reversal agent for the antiplatelet drug ticagrelor and is currently undergoing Phase III clinical trials for patients experiencing uncontrolled bleeding or requiring urgent surgery. The company is also advancing PB1046, a fusion protein aimed at treating pulmonary arterial hypertension, which is in Phase IIb clinical trials. Additionally, PhaseBio is developing PB6440, an oral agent intended for the treatment of resistant hypertension. Founded in 2002, the company leverages proprietary recombinant biopolymers to enhance the stability and efficacy of its drug candidates.

Masse

Seed Round in 2018
Masse is a mobile app which recommends products from people you trust.

Akouos

Series A in 2018
Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.

Formlabs

Series D in 2018
Formlabs Inc. specializes in designing and manufacturing 3D printing systems aimed at professionals in various fields, including engineering, design, education, healthcare, and jewelry. Founded in 2011 and headquartered in Somerville, Massachusetts, the company has expanded its presence internationally with offices in Germany, Japan, China, Singapore, Hungary, and North Carolina. Formlabs' product lineup features advanced 3D printers, such as the Form 3, Form 3B, and Fuse 1, which utilize Low Force Stereolithography (LFS) technology to deliver high-resolution prints. Additionally, the company provides a range of materials, including standard, castable, flexible, tough, and dental SG options, along with software tools like PreForm for model preparation. Formlabs is recognized for its commitment to innovation, offering post-processing solutions and manufacturing systems that cater to the needs of engineers, designers, and makers worldwide.

Trevi Therapeutics

Series C in 2018
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, dedicated to developing and commercializing nalbuphine ER, an investigational therapy. The company's lead product, Haduvio, is an oral extended-release formulation of nalbuphine currently undergoing Phase IIb/III clinical trials. Trevi Therapeutics is focused on addressing serious neurologically mediated conditions, including chronic pruritus, chronic cough associated with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in Parkinson's disease patients. The ongoing PRISM trial evaluates Haduvio's effectiveness in treating severe pruritus related to prurigo nodularis, highlighting its potential in managing conditions linked by a common pathophysiology involving opioid receptors in the nervous system. Founded in 2011, Trevi Therapeutics aims to provide innovative therapeutic solutions for patients with significant unmet medical needs.